Drug information for NIMODIPINE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL 30MG Prescription AB  NIMODIPINE Nimodipine BANNER PHARMACAPS 76740
2012-01-27 Review

2010-08-09 Other Important Information from FDA
CAPSULE; ORAL 30MG Prescription AB (Reference Drug) NIMODIPINE Nimodipine SUN PHARM INDS INC 77067
2010-08-09 Other Important Information from FDA

2007-04-25 Letter
CAPSULE; ORAL 30MG Prescription AB  NIMODIPINE Nimodipine BARR LABS INC 77811
2010-08-09 Other Important Information from FDA

Drug Adverse Effects information for NIMODIPINE

Role code Indications Reaction # Reports
C CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE HEART RATE ABNORMAL 2
C CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE SYNCOPE 2
C DEMENTIA HEART RATE ABNORMAL 2
C DEMENTIA SYNCOPE 2
C HYPERLIPIDAEMIA BLOOD CREATINE PHOSPHOKINASE INCREASED 1
C HYPERLIPIDAEMIA HYPOTHYROIDISM 1
C HYPERTENSION ACUTE MYOCARDIAL INFARCTION 2
C HYPERTENSION HEART RATE ABNORMAL 2
C HYPERTENSION RESPIRATORY ARREST 1
C HYPERTENSION SYNCOPE 2
C HYPERTENSION THROMBOCYTOPENIA 2
C MULTIPLE MYELOMA ACUTE MYOCARDIAL INFARCTION 2
C MULTIPLE MYELOMA THROMBOCYTOPENIA 2
C OSTEOPOROSIS AORTIC ANEURYSM 1
C OSTEOPOROSIS COLITIS 1
C OSTEOPOROSIS CORONARY ARTERY DISEASE 1
C OSTEOPOROSIS DISCOMFORT 1
C OSTEOPOROSIS HYPERTENSION 1
C OSTEOPOROSIS PAIN IN EXTREMITY 1
C PARKINSON'S DISEASE HEART RATE ABNORMAL 2
C PARKINSON'S DISEASE SYNCOPE 2
C RELAPSING-REMITTING MULTIPLE SCLEROSIS DYSARTHRIA 1
C RELAPSING-REMITTING MULTIPLE SCLEROSIS DYSPHAGIA 1
C RELAPSING-REMITTING MULTIPLE SCLEROSIS MULTIPLE SCLEROSIS RELAPSE 1
C RELAPSING-REMITTING MULTIPLE SCLEROSIS TRANSIENT ISCHAEMIC ATTACK 1
Ads by Google